Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
Prophylactic and therapeutic effects of aspirin in cancer.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Peralta Lizet Díaz, Torres Erika Itayetzi Hernández, García Ana Isabel Burguete, Flores Fernando Luis Reyna, Morales Victor Hugo Bermúdez
Аннотация
Aspirin (acetylsalicylic acid) is the oldest synthetic drug and is recognized for its analgesic, antipyretic, antiplatelet effects, and mediators in inflammation. The available research evidence shows that aspirin prevents precursor lesions and cancers, and has therapeutic properties against certain cancer types. This review explores the pharmacological properties of low-dose aspirin related to its preventive effects on cancer, emphasizing the possible mechanisms of action involved in cancer control. It discusses the modulation of signaling pathways related to inflammation, regulation of the cell cycle and apoptosis, inhibition of angiogenesis associated with tumor growth, inhibition of metastasis, and regulation of the immune response. Furthermore, aspirin could be a very promising drug for adjuvant treatment in cancer patients and with implications in the prevention of certain types of cancer.